Eyepoint Pharmaceuticals Inc is a global pharmaceutical company focused on the development and commercialisation of therapies for eye-related ailments. Its primary operations are focused on curative treatment, production and distribution.
Operating in the biotechnology industry, Eyepoint Pharmaceuticals Inc has a retinal disease-focused pipeline that uses its proprietary Durasert technology to achieve intraocular drug delivery. Its product portfolio includes EYP-1901, an intravitreal anti-VEGF treatment that is targeted at age-related macular degeneration. Its expertise lies in the pharmaceuticals and therapeutics industry.
Stay up to date on the share price of EYPT by adding it to your eToro watchlist.